Cargando…
Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence
Autores principales: | Dreyer, Stephan B., Upstill-Goddard, Rosie, Legrini, Assya, Biankin, Andrew V., Jamieson, Nigel B., Chang, David K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
W.B. Saunders
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721486/ https://www.ncbi.nlm.nih.gov/pubmed/34534536 http://dx.doi.org/10.1053/j.gastro.2021.09.022 |
Ejemplares similares
-
The Impact of Molecular Subtyping on Pathological Staging of Pancreatic Cancer
por: Dreyer, Stephan B., et al.
Publicado: (2023) -
Clinical and Molecular Risk Factors for Recurrence Following Radical Surgery of Well-Differentiated Pancreatic Neuroendocrine Tumors
por: Pulvirenti, Alessandra, et al.
Publicado: (2020) -
Molecular Subtyping and Precision Medicine for Pancreatic Cancer
por: Froeling, Fieke E. M., et al.
Publicado: (2021) -
Using Chromatin Accessibility to Delineate Therapeutic Subtypes in Pancreatic Cancer Patient-Derived Cell Lines
por: Brunton, Holly, et al.
Publicado: (2020) -
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer
por: Brunton, Holly, et al.
Publicado: (2020)